Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...

Indian stock markets showed divergence as Sensex closed lower and Nifty ended higher. Sharp swings occurred during the closing auction sess...

The healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procu...

Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...

On September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...

Indian markets experienced a sharp decline on Wednesday due to global factors. Technical analysis suggests further downside potential for t...

Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...

Sun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...

Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...

Bank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower speciality exec...

Sun Pharma Q1 Results: Sun Pharma reported a 40% increase in consolidated net profit to Rs 2,836 crore, surpassing estimates of Rs 2,638 cr...

Concert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...

As part of the strategy to stay ahead of its rivals in the highly fragmented domestic formulation business, Sun Pharma has embarked on majo...

Adjusted net profit for the quarter was at Rs 1,582.1 crore, up by 18 per cent YoY, after excluding the exceptional items of Rs 3,935.7 cro...

The company said during the quarter and year ended March 31, 2022 the company incurred a one-time cost of Rs 56.35 crore in relation to res...

The United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol f...